Scientific Advisors

OvaGene's scientific advisors are highly qualified and experienced in gynecologic cancers and are committed to ensuring that women are provided with the best diagnostic technologies available for gynecologic cancer management.  OvaGene's advisory boards include highly respected oncologists and scientists from top cancer centers worldwide who are advising OvaGene on clinical matters such as evaluating currently unmet needs in the treatment of gynecologic cancers.


Scientific Advisors

Robert E. Bristow, MD, MBA, FACS
Professor, Department of Obstetrics and Gynecology
Director, Division of Gynecologic Oncology, University of California, Irvine 

Bruce A. Chabner, MD
Professor, Department of Medicine, Harvard Medical School
Clinical Director, MGH Cancer Center, Massachusetts General Hospital

Philip J. DiSaia, MD
Professor and Director, Division of Gynecologic Oncology, University of California, Irvine
Dorothy J. Marsh Chair in Reproductive Biology, Obstetrics/Gynecology, UC Irvine
Chair, The Gynecologic Oncology Group (GOG)

Vincent T. DeVita, MD
Professor, Yale Medical School, Past Director of Yale Cancer Center
Former Director of the National Cancer Institute (NCI)

Victor Ling, PhD
President and Scientific Director of the Terry Fox Research Institute
Professor of Pathology and Laboratory Medicine, The University of British Columbia

Sergio Pecorelli, MD
Chairman of the Department of Obstetrics and Gynecology and Director of Gynecologic Oncology and Pelvic Surgery, University of Brescia, Italy
Chairman, Italian Drug Administration, President International Federation of Gynecologic Oncologists

Ralph Scully, PhD
Assistant Professor, Department of Medicine, Harvard Medical School
Associate Professor, Department of Medicine, Beth Israel Deaconess Medical Center

Ignace B. Vergote, MD
Professor and Director, Division of Gynecologic Oncology, Catholic University of Leuven, Belgium
Chairman, EORTC Research and Cancer Treatment, Protocol Committees
President, EU Society of Gynecologic Oncology, International Gynecologic Cancer Society